Jun 18, 2020
Asthma Not Associated With Increased Risk of Hospitalization Among COVID-19 Patients
Jun 16, 2020
Nasal Drug Delivery Devices Market Size to Exceed US$ 78.3 Bn by 2027
Jun 15, 2020
COVID-19 Associated with Dramatic Decline in Use of Emergency Department by Pediatric Asthma Patients
Jun 11, 2020
Electronic Drug Delivery Systems Market Worth $14.51 Billion, Globally, by 2027 at 8.5% CAGR: Verified Market Research
Jun 08, 2020
Nuvaira Announces FDA Breakthrough Designation for AIRFLOW-3 Pivotal Trial Device
Jun 05, 2020
Sosei Heptares Notes Phase IIIb ARGON Study With Enerzair® Breezhaler® (QVM149) Meets Primary Endpoint in Patients With Uncontrolled Asthma
May 19, 2020
Nebulizers' Demand Grows as Coronavirus Cases Rise, TBRC Report Suggests
May 19, 2020
Teva Canada Secures Salbutamol Inhalers from its Global Supply Chain to Mitigate Shortage in Canadian Market
May 05, 2020
Allergy & Asthma Network to Host Virtual Advocacy Day on May 20, Launch Telehealth Coach Program, And More
May 01, 2020
Sosei Heptares Notes That Enerzair® Breezhaler® (QVM149) has been Recommended for Approval in the European Union for Treating Uncontrolled Asthma
Apr 30, 2020
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth
Apr 30, 2020
Asthma Action Hero App Could Help Children Stay Safe During COVID-19
Apr 29, 2020
Convexity Scientific Teams with Right2Breathe During National Asthma and Allergy Awareness Month
Apr 28, 2020
Surge in Demand for Anti-asthmatics and COPD Drugs due to Coronavirus, Reports TBRC
Apr 24, 2020
COVID-19 Impact on the Nebulizers Industry, 2020-2030 - Increased Use of Albuterol Inhalers in Hospitals for COVID-19 Treatment
Apr 17, 2020
Advisory - Shortage of salbutamol inhalers in Canada
Apr 16, 2020
Study Finds Number of Asthma Biologic Medication Users and Spend Doubled Over 2.5 Years
Apr 16, 2020
United States Respiratory Drug Industry Analysis 2019-2025 - Rising Prevalance of Asthma is the Main Catalyst of Growth
Apr 09, 2020
Cipla Receives Final Approval for Generic Version of Proventil® HFA Inhalation Aerosol (Albuterol Sulfate Inhalation Aerosol 90mcg (Base)/Actuation)
Apr 08, 2020
FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent Bronchospasm